On May 11, 2024, China State Administration for Market Regulation (SAMR) released Clinical Trial Qualitferrous fumarate chewable tabletsy Management Standard for Foferrous bisglycinate reviewods fgluconate ironor Special Medical Purpose (hereinafter “FSMP Cliferrous fumarate 300 mg 100 mg iron capsulenical Trial Standard"), which applies to the clinical trial conducted for FSMP registration in China. This nedta iron sodium saltew regulation has been effective starting from the date of promulgation, and its previous trial version issued on October 13, 2016 has been repealed since then.
China Updates the Clinical Trial Quality Management Standard for Foods for Special Medical Purpose
